Invacare Corporation designs, manufactures, and distributes medical equipment and supplies used in the home and long-term care settings. It operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. The company was founded in 1885 and is based in Elyria, Ohio.
IVC Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for IVC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Invacare Corp ranked in the 4th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Invacare Corp, consider:
The stock's equity weight, or the proportion of capital from equity relative to debt, is 46. Its equity weight surpasses that of only 16.28% of free cash flow generating stocks in the Healthcare sector.
Its compound free cash flow growth rate, as measured over the past 5.01 years, is -0.07% -- higher than only 16.29% of stocks in our DCF forecasting set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
FGEN, PHG, SSKN, ATRS, and CRY can be thought of as valuation peers to IVC, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will present at the Lytham Partners Virtual Investor Growth Conference on Wednesday, October 7, 2020 at 9:00 a.m. ET. The live audio cast will be available at https://www.webcaster4.com/Webcast/Page/2513/37778 and it will be accessible for replay for 90 days following the conference.
Invacare Corporation (IVC) has retired ~$22M, the majority of its remaining 5% Convertible Senior Notes due 2021, leaving a balance of ~$3.8M of 2021 convertible notes outstanding. “By opportunistically repurchasing the notes, including some at slightly below par, we continue to set the foundation for long-term profitable growth with a...
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) announced today it has retired the majority of its remaining 5% Convertible Senior Notes due 2021. The company repurchased approximately $22.0 million aggregate principal amount of the 2021 convertible notes for cash in separate open market transactions, leaving a balance of approximately $3.8 million aggregate principal amount of 2021 convertible notes outstanding. “I’m pleased we were able to retire the significant majority our r